RxDoctor Payments Data

Joseph Barker, MD

Orthopaedic Surgery · Raleigh, NCNPI 1518133800

Payments from drug & device makers

$86,827in general payments, 2019–2025

Across 139 payments — averaging $624.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$80K
  • Arthrex$5K
  • Pacira Pharmaceuticals Incorporated$500
  • Tricoast Surgical Solutions LLC$296
  • Moximed, Inc$242
  • Smith+Nephew$191
  • plus $989 from 14 others

What the payments were for

  • Consulting fees$67,92578%
  • Speaking & faculty fees$4,2505%
  • Travel & lodging$10,04112%
  • Food & beverage$4,6125%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)75$80,013
Arthrex16$4,597
Pacira Pharmaceuticals Incorporated1$500
Tricoast Surgical Solutions LLC7$296
Moximed, Inc6$242
Smith+Nephew3$191
Illuminoss Medical, Inc.2$165
Ossur Americas, Inc.1$141
Ferring Pharmaceuticals Inc.7$127
Linvatec Corporation1$120
Vericel Corporation6$88
Arthrosurface Incorporated1$81
Boston Scientific2$57
Amgen3$56
Almatica Pharma LLC2$44
Radius Health, Inc.2$38
Trice Medical, Inc.1$22
Abbott1$18
Cartiheal (2009) LTD.1$17
Johnson & Johnson1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$86,827 in reported general payments places this provider in the 85th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$157,524
Medicare patients
311
Services billed
1,664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib31$534
Meloxicam48$155

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →